Suggestions
Trudi Haemmerli
Venture Capital I Angel Investor I Board Member I Consultant
Trudi Haemmerli is a seasoned Business Angel Investor with a focus on Pharma, Medtech, and ICT industries. She currently serves as the Vice Chairperson of the Board for Innosuisse, the Swiss Innovation Agency, and provides advisory and consulting services to SMEs in the Pharma and Medtech sectors.
With a strong background in the pharmaceutical industry, Trudi has honed her skills in global leadership, operational management, and project management. Known for her problem-solving abilities and team-building skills, she has expertise in Regulatory Affairs, Technical R&D, and R&D Operations. Her experience includes leading key projects in IT system development, laboratory design, and drug manufacturing on a global scale.
Having completed a part-time MBA in 2014, Trudi transitioned from corporate Pharma to the entrepreneurial world. She has taken on roles as a startup CEO and a Business Angel investor. Trudi's involvement in the Swiss Commission for Technology and Innovation and her current position at Innosuisse further showcase her commitment to fostering innovation and entrepreneurship.
Trudi's educational background is impressive, with a Masters in Business Administration from the University of St.Gallen, along with executive diplomas from the University of St. Gallen & ESADE Business School. She also holds degrees in Pharmaceutical Research & Development and Chemistry from reputable institutions.
Throughout her career, Trudi has been associated with esteemed organizations such as Technologiepark Basel, SNGLR Group, Swiss Health Angels, and Innosuisse. Her previous roles at Novartis International AG highlight her leadership journey, from Global Regulatory CMC Head to Compliance Director.
Trudi's broad experience encompasses various positions in regulatory affairs, research operations, and project management. Her transition to entrepreneurship and angel investing demonstrates her adaptability and strategic vision in the ever-evolving industries she operates in.
Highlights
Friends and colleagues,
Thank you for the outpour of support and kind words in the wake of Trudi’s passing. She had an indelible impact on many in the Swiss business community. Her legacy as a mentor and dear friend will live on in cherished memory.
Unfortunately, we cannot respond to every message – but your condolences are greatly appreciated.
Stephan and family
We are saddened to announce Trudi passed away last week on Monday morning, June 24, during her vacation in Kenya. We understand this news may be surprising to some.
Although her health deteriorated quite rapidly, it was not completely unexpected. Trudi had courageously fought breast cancer for more than two years. Her cancer was exceptionally aggressive. These cases are less common—she was simply unlucky.
Even so, her joyful outlook on life inspired us all. She celebrated every moment and never backed down from any challenges thrown her way.
Despite the shortened time frame, Trudi achieved her aspirations and lived to the fullest. She touched countless lives—as a proud mother, wife, friend, and mentor to so many around her.
The medical team at Aga Khan University Hospital in Nairobi provided excellent care during Trudi’s final hours. Her husband and close friends remained by her side until she died peacefully, contented with her accomplishments and legacy.
Even while united in grief, the future remains bright.
Stephan, Tobias, Alex, Benjamin, and Dot
